|
|
|
|
| LEADER |
02203nmm a2200325 u 4500 |
| 001 |
EB000658386 |
| 003 |
EBX01000000000000000511468 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783540481461
|
| 100 |
1 |
|
|a Leeper, Finian J.
|e [editor]
|
| 245 |
0 |
0 |
|a Biosynthesis
|h Elektronische Ressource
|b Aromatic Polyketides, Isoprenoids, Alkaloids
|c edited by Finian J. Leeper, John C. Vederas
|
| 250 |
|
|
|a 1st ed. 2000
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 2000, 2000
|
| 300 |
|
|
|a X, 247 p. 4 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Biosynthesis of Aromatic Polyketides -- Cyclization Enzymes in the Biosynthesis of Monoterpenes, Sesquiterpenes, and Diterpenes -- Biosynthesis of Prenylated Alkaloids Derived from Tryptophan -- Tropane and Related Alkaloids -- Biosynthesis and Metabolism of Pyrrolizidine Alkaloids in Plants and Specialized Insect Herbivores
|
| 653 |
|
|
|a Chemical Bioengineering
|
| 653 |
|
|
|a Chemistry, Organic
|
| 653 |
|
|
|a Biotechnology
|
| 653 |
|
|
|a Biochemistry
|
| 653 |
|
|
|a Organic Chemistry
|
| 700 |
1 |
|
|a Vederas, John C.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Topics in Current Chemistry
|
| 028 |
5 |
0 |
|a 10.1007/3-540-48146-X
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/3-540-48146-X?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 660.63
|
| 520 |
|
|
|a This book is the second of two volumes that deal with discovery of chemical pathways of biosynthesis of natural products (secondary metabolites). Volume 1 covered the use of isotopes in biosynthetic research and the formation of enzyme cofactors and reduced polyketides. This second volume describes biosynthesis of aromatic (unreduced) polyketides, enzymes responsible for cyclization of terpenoids (isoprenoids), and biochemical generation of selected classes of alkaloids (prenylated tryptophan, tropane, pyrrolizidine). Knowledge of the pathways and the techniques to elucidate them opens the door to combinatorial biosynthesis as well as to the production of targeted pharmaceutical agents utilizing a combination of chemistry, molecular biology and protein biochemistry
|